Cerivastatin, a new synthetic HMG CO-A reductase inhibitor in the treatment of patients with primary hyperlipidaemia

被引：0
|
作者：
Kukharchuk, VV [1 ]
Solovieva, EY [1 ]
Rozhkova, TA [1 ]
Tvorogova, MG [1 ]
机构：
[1] Cardiol Res Ctr, Inst Clin Cardiol, Moscow, Russia
来源：
ATHEROSCLEROSIS | 1999年 / 144卷
关键词：
D O I：
10.1016/S0021-9150(99)80751-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：196 / 197
页数：2
相关论文
共 50 条
  • [41] STIMULATION OF ENDOTHELIAL PROGENITOR CELLS: A NEW PUTATIVE THERAPEUTIC EFFECT OF HMG CO-A REDUCTASE INHIBITOR IN ANKYLOSING SPONDYLITIS: STAT-AS STUDY
    Syngle, D.
    Garg, N.
    [J]. ATHEROSCLEROSIS, 2022, 355 : E334 - E334
  • [42] ENANTIOCONVERGENT SYNTHESIS OF A PROMISING HMG CO-A REDUCTASE INHIBITOR NK-104 FROM BOTH ENANTIOMERS OF EPICHLOROHYDRIN
    TAKANO, S
    KAMIKUBO, T
    SUGIHARA, T
    SUZUKI, M
    OGASAWARA, K
    [J]. TETRAHEDRON-ASYMMETRY, 1993, 4 (02) : 201 - 204
  • [43] Phase I study to investigate the effects of cimetidine on the pharmacokinetics of cerivastatin - A new HMG-CoA reductase inhibitor
    Frey, R
    Ritter, W
    Unger, S
    Ochmann, K
    Wingender, W
    [J]. ATHEROSCLEROSIS, 1997, 130 : 103 - 103
  • [44] Cerivastatin - A new HMG-CoA reductase inhibitor - In combination with the antacid Maalox(R): An investigation of the safety and pharmacokinetics
    Dietrich, H
    Ritter, W
    Wingender, W
    Unger, S
    Ochmann, K
    [J]. ATHEROSCLEROSIS, 1997, 130 : 101 - 101
  • [45] Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition
    Dechend, R
    Fiebler, A
    Lindschau, C
    Bischoff, H
    Müller, D
    Park, JK
    Dietz, R
    Haller, H
    Luft, FC
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (06) : 55S - 61S
  • [46] In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor
    Feleszko, W
    Mlynarczuk, I
    Nowis, D
    [J]. FEBS LETTERS, 2001, 503 (2-3) : 219 - 220
  • [47] Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin
    Mück, W
    Unger, S
    Kawano, K
    Ahr, G
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (06) : 583 - 590
  • [48] The HMG-CoA reductase inhibitor cerivastatin enhances the nitric oxide bioavailability of the endothelium
    Berkels, R
    Nouri, SK
    Taubert, D
    Bartels, H
    Roesen, P
    Roesen, R
    Klaus, WF
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 (03) : 356 - 363
  • [49] HMG Co-A reductase inhibitors improve renal hemodynamics and function in renal ischemia
    Chade, AR
    Krier, JD
    Lerman, A
    Lerman, LO
    [J]. CIRCULATION, 2004, 110 (17) : 313 - 313
  • [50] Treatment of mixed hyperlipidaemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor
    Bhatnagar, D
    Mackness, MI
    Durrington, PN
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0D) : D53 - D58
12345